Welcome to #1 DIGITAL HEALTH NEWS Portal

Heart Attacks could be Ruled Out Early with New Test, Researchers Find

As many as 60% of people presenting to emergency departments around the world with heart attack symptoms could be safely sent home, many at earlier stages, with the support of a new high-sensitivity cardiac troponin test, researchers in the US have found.

The assay from global health technology provider Mindray allows clinical teams to measure cardiac troponin I proteins that are released into the blood during heart attacks, and when the heart is damaged.

Read more ...

Northern Ireland's Laboratory Services Reach another IT Milestone

The transformation of pathology services across Northern Ireland has achieved another milestone, with the completion of phase three of the CoreLIMS programme to deploy Clinisys WinPath to all five health and social care trusts and the blood transfusion service.

Phase three was completed in late October, when Northern Health and Social Care Trust went live with the laboratory information management system in blood sciences and microbiology, and the national cervical cytology screening service hosted by Belfast Health and Social Care Trust adopted the LIMS.

Read more ...

NIH-Developed AI Algorithm Successfully Matches Potential Volunteers to Clinical Trials Release

Researchers from the National Institutes of Health (NIH) have developed an artificial intelligence (AI) algorithm to help speed up the process of matching potential volunteers to relevant clinical research trials listed on ClinicalTrials.gov. A study published in Nature Communications found that the AI algorithm, called TrialGPT, could successfully identify relevant clinical trials for which a person is eligible and provide a summary that clearly explains how that person meets the criteria for study enrollment.

Read more ...

In 10 Seconds, an AI Model Detects Cancerous Brain Tumor often Missed During Surgery

Researchers have developed an AI powered model that - in 10 seconds - can determine during surgery if any part of a cancerous brain tumor that could be removed remains, a study published in Nature suggests.

The technology, called FastGlioma, outperformed conventional methods for identifying what remains of a tumor by a wide margin, according to the research team led by University of Michigan and University of California San Francisco.

Read more ...

MEDICA 2024 and COMPAMED 2024: Medical Technology Industry Uses Global Reach to Compete for Innovation Leadership

11 - 14 November 2024, Düsseldorf, Germany.
"Meet Health. Future. People." is MEDICA's campaign motto for the future in the new trade fair year 2025. The aptness of the motto was confirmed by the success of MEDICA 2024 and its concurrently held number 1 supplier trade fair, COMPAMED 2024. "The best options for global networking were on offer, along with an incredible variety of cutting-edge innovations and top-level programme highlights. MEDICA is unique in its global reach", says Marius Berlemann, Chief Operating Officer of Messe Düsseldorf, clearly impressed by all that happened at the exhibition booths and on the programme stages.

Read more ...

Does AI Improve Doctors' Diagnoses?

With hospitals already deploying artificial intelligence to improve patient care, a new study has found that using Chat GPT Plus does not significantly improve the accuracy of doctors' diagnoses when compared with the use of usual resources.

The study, from UVA Health’s Andrew S. Parsons, MD, MPH and colleagues, enlisted 50 physicians in family medicine, internal medicine and emergency medicine to put Chat GPT Plus to the test.

Read more ...

AI Analysis of PET/CT Images can Predict Side Effects of Immunotherapy in Lung Cancer

Dr. Watanabe and his teams from Niigata University have revealed that PET/CT image analysis using artificial intelligence (AI) can predict the occurrence of interstitial lung disease, known as a serious side effect of immunotherapy in lung cancer.

Immunotherapy has dramatically improved the treatment outcomes of primary lung cancer; however, it sometimes causes a serious side effect called interstitial lung disease.

Read more ...

New Medical AI Tool Identifies more Cases of Long COVID from Patient Health Records

Investigators at Mass General Brigham have developed an AI-based tool to sift through electronic health records to help clinicians identify cases of long COVID, an often mysterious condition that can encompass a litany of enduring symptoms, including fatigue, chronic cough, and brain fog after infection from SARS-CoV-2. The results, which are published in the journal Med, could identify more people who should be receiving care for this potentially debilitating condition. The number of cases they identified also suggests that the prevalence of long COVID could be greatly underrecognized.

Read more ...

MEDICA and COMPAMED 2024: Shining a Light on Healthcare Trends with Ample Array of Innovations, Exciting Formats and VIP Guests

11 - 14 November 2024, Düsseldorf, Germany.
Christian Grosser, Director Health & Medical Technologies, is looking forward to events getting under way: "From next Monday to Thursday, we will once again be welcoming visiting professionals from all fields of the international healthcare industry to MEDICA and COMPAMED 2024. The trade fairs will offer an enormous variety of innovations and exciting programme formats with a host of highlights, innovations and top-class speakers." From 11 to 14 November, 5,800 exhibitors from 72 countries will fill the entire hall space on the trade fair grounds.

Read more ...

Siemens Healthineers co-leads EU Project to Improve Stroke Care

Siemens Healthineers is joining forces with more than 20 industry and public partners, including seven leading stroke hospitals, to improve stroke management for patients all over Europe. With a total volume of €26.9 million, the five-year UMBRELLA(1) project is partly funded by the Innovative Health Initiative (IHI), a public-private partnership for health research and innovation between the European Union and Europe's life science industries, and partly by the industry partners participating in the consortium.

Read more ...